Jacob Gaines
Mount Sinai Hospital
11 Papers
8 Citations
Jacob Gaines is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma.
Xiao X. Wei,Lillian Werner,Min Y. Teo,Jonathan E. Rosenberg,Vadim S. Koshkin,Petros Grivas,Bernadett Szabados,Laura Morrison,Thomas Powles,Lucia Carril-Ajuria,Daniel Castellano,Pedro Isaacsson Velho,Noah M. Hahn,Rana R. McKay,Daniele Raggi,Andrea Necchi,Ravindran Kanesvaran,Parissa Alerasool,Jacob Gaines,Matthew D. Galsky,Joaquim Bellmunt,Guru Sonpavde +21 more
TL;DR: In this biomarker-unselected cohort of cisplatin-ineligible patients with mUC, PD-1/L1 inhibitor followed by carboplatin-containing chemotherapy and the reverse sequence had comparable OS.
5
First-line PD-1/PD-L1 inhibitor followed by carboplatin (carbo)-based chemotherapy (chemo) or the reverse sequence in cisplatin-ineligible metastatic urothelial cancer (mUC) patients (pts).
Xiao X. Wei,Kevin Lundgren,Min Yuen Teo,Jonathan E. Rosenberg,Vadim S. Koshkin,Petros Grivas,Lucia Carril,Daniel Castellano,Pedro Isaacsson Velho,Noah M. Hahn,Rana R. McKay,Daniele Raggi,Andrea Necchi,Ravi Kanesvaran,Parissa Alerasool,Jacob Gaines,Laura Morrison,Thomas Powles,Joaquim Bellmunt,Guru Sonpavde +19 more
TL;DR: A multicenter retrospective analysis of cisplatin-ineligible mUC pts treated with first-line PD-1/PD-L1 monotherapy followed by carbo-based chemo found that optimal first- line therapy and sequencing of these regimens is unclear.
3
Treatment sequencing of anti-PD-1/PD-L1 and carboplatin (carbo)-based chemotherapy (chemo) in cisplatin-ineligible patients (pts) with metastatic urothelial cancer (mUC).
Xiao X. Wei,Lillian Werner,Min Yuen Teo,Jonathan E. Rosenberg,Vadim S. Koshkin,Petros Grivas,Bernadett Szabados,Laura Morrison,Lucia Carril,Daniel Castellano,Pedro Isaacsson Velho,Noah M. Hahn,Rana R. McKay,Daniele Raggi,Andrea Necchi,Ravindran Kanesvaran,Parissa Alerasool,Jacob Gaines,Joaquim Bellmunt,Guru Sonpavde +19 more
TL;DR: This data indicates that pro-PD-1/PD-L1 agents and carbo-based chemo are therapy options in 1st-line (1L) setting for cisplatin-ineligible pts with mUC but optimal sequencing is unclear.
1
Mp09-16 informing an approach to the subcapsular renal hematoma (srh): a ten-year review of the natural history and progression of srh
Elizabeth Lynch,Jacob Gaines,Justin James,Tareq Aro,David M. Hoenig,Zeph Okeke,Arthur R. Smith,Arun Rai +7 more
TL;DR: Ateniese et al. as mentioned in this paper presented a 10-year review of the history and progress of subcapsular renal hematoma (SRH) in nine Northwell Health hospitals, including a Level 1 Trauma Center from 2011 to 2021.
V13-11 single port robot-assisted laparoscopic adrenalectomy via mini pfannenstiel incision
Justin James,Arun Rai,Jacob Gaines,E. Macdonald,Manish Vira +4 more
- 01 May 2022
TL;DR: LPA using a linear stapling device is a valid alter-native to total adrenalectomy when normal adrenal tissue has to be preserved and is presented here the feasibility of mini Pfannenstiel incision for single port upper tract urologic surgery.